Access to essential drugs and globalization

Development

Volumn 42, Issue 4, 1999, Pages 87-91

  'T Hoen, Ellen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE TREATMENT; GLOBALIZATION; HEALTH CARE; INTERNATIONAL TRADE;

EID: 0033503083     PISSN: 10116370     EISSN: 14617072     Source Type: Journal    
DOI: 10.1057/palgrave.development.1110092     Document Type: Article

References (10)

1. Financial Times (29 March 1999) Campaign over Drug Licensing to Grow.
2. IFPMA (1998) The Question of Patents. The Key to Medical Progress and Industrial Development. Geneva: IFPMA.
3. IFPMA (26 March 1999) Statement released at a meeting on 'Compulsory Licensing and Access to Essential Drugs'.
4. Love, J. (1997) 'Call for More Reliable Costs Data On Clinical Trials', Markelletter, 13 January.
5. Pecoul, B. (1999) 'Sleeping Sickness, after Three Years of Negotiations'. Medecines Dossier. Paris: Médicins sans Frontières.
6. Pécoul, B., P. Chirac, P. Trouiller and J. Pinel (1999) 'Access to Essential Drugs in Poor Countries. A lost Battle?', JAMA, 281.
7. Prescrire (1999) 'Enrichir sa panoplie thérapeutique. Bilan de l'année 1998'. Vol 91, January.
8. Scholtz, M. (1999) Presentation at the meeting on Compulsory Licensing of Essential Medicines. Geneva, 26 March.
9. WHO (1999a) The World Health Report. Making a Difference. Geneva: World Health Organization.
10. WHO (1999b) Globalization and Access to Drugs. Perspectives on the WTO/TRIPS Agreement. Health Economics and Drugs. DAP series no. 7, rev. Geneva: World Health Organization.